Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2

被引:0
|
作者
Rosanna Cardani
Marzia Giagnacovo
Annalisa Botta
Fabrizio Rinaldi
Alessandra Morgante
Bjarne Udd
Olayinka Raheem
Sini Penttilä
Tiina Suominen
Laura V. Renna
Valeria Sansone
Enrico Bugiardini
Giuseppe Novelli
Giovanni Meola
机构
[1] IRCCS Policlinico San Donato,Lab of Muscle Histopathology and Molecular Biology
[2] University of Milan,CMN
[3] University of Pavia,Neuromuscular Disease Center, IRCCS Policlinico San Donato
[4] Tor Vergata University of Rome,Department of Animal Biology
[5] University of Tampere,Department of Biopathology and Diagnosing Imaging
[6] University of Helsinki,Neuromuscular Research Unit
[7] University of Helsinki,Department of Medical Genetics, Haartman Institute
[8] Tampere University Hospital,Department of Medical Genetics, Folkhälsan Institute of Genetics
[9] Vaasa Central Hospital,Department of Neurology
[10] University of Milan,Department of Neurology
[11] San Peter Hospital,Department of Neurology, IRCCS Policlinico San Donato
[12] National Agency for the Evaluation of Universities and Research,undefined
[13] ANVUR,undefined
来源
Journal of Neurology | 2012年 / 259卷
关键词
Myotonic dystrophy type 2; Juvenile case; Muscle pathology; Myotonia congenita;
D O I
暂无
中图分类号
学科分类号
摘要
Myotonic dystrophy type 2 (DM2) is a common adult onset muscular dystrophy caused by a dominantly transmitted (CCTG)n expansion in intron 1 of the CNBP gene. In DM2 there is no obvious evidence for an intergenerational increase of expansion size, and no congenital cases have been confirmed. We describe the clinical and histopathological features, and provide the genetic and molecular explanation for juvenile onset of myotonia in a 14-year-old female with DM2 and her affected mother presenting with a more severe phenotype despite a later onset of symptoms. Histological and immunohistochemical findings correlated with disease severity or age at onset in both patients. Southern blot on both muscle and blood samples revealed only a small increase in the CCTG repeat number through maternal transmission. Fluorescence in situ hybridization, in combination with MBNL1 immunofluorescence on muscle sections, showed the presence of mutant mRNA and MBNL1 in nuclear foci; the fluorescence intensity and its area appeared to be similar in the two patients. Splicing analysis of the INSR, CLCN1 and MBNL1 genes in muscle tissue demonstrates that the level of aberrant splicing isoforms was lower in the daughter than in the mother. However, in the CLCN1 gene, a heterozygous mutation c.501C>G p.F167L was present in the daughter’s DNA and found to be maternally inherited. Biomolecular findings did not explain the unusual young onset in the daughter. The co-segregation of DM2 with a recessive CLCN1 mutation provided the explanation for the unusual clinical findings.
引用
收藏
页码:2090 / 2099
页数:9
相关论文
共 50 条
  • [1] Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2
    Cardani, Rosanna
    Giagnacovo, Marzia
    Botta, Annalisa
    Rinaldi, Fabrizio
    Morgante, Alessandra
    Udd, Bjarne
    Raheem, Olayinka
    Penttila, Sini
    Suominen, Tiina
    Renna, Laura V.
    Sansone, Valeria
    Bugiardini, Enrico
    Novelli, Giuseppe
    Meola, Giovanni
    JOURNAL OF NEUROLOGY, 2012, 259 (10) : 2090 - 2099
  • [2] Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2)
    Santoro, Massimo
    Modoni, Anna
    Masciullo, Marcella
    Gidaro, Teresa
    Broccolini, Aldobrando
    Ricci, Enzo
    Tonali, Pietro Attilio
    Silvestri, Gabriella
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2010, 89 (02) : 158 - 168
  • [3] Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2)
    Gaul, C.
    Schmidt, T.
    Windisch, G.
    Wieser, T.
    Mueller, T.
    Vielhaber, S.
    Zierz, S.
    Leplow, B.
    NEUROLOGY, 2006, 67 (02) : 350 - 352
  • [4] Oculomotor involvement in myotonic dystrophy type 2 (DM2)
    Ajroud-Driss, Senda
    Siddique, Teepu
    Sufit, Robert
    Hain, Timothy
    NEUROLOGY, 2007, 68 (12) : A298 - A299
  • [5] Myotonic dystrophy type 2 (DM2) in Minnesota.
    Day, J
    Liquori, C
    Johnson, C
    Durand, A
    Ranum, L
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 333 - 333
  • [6] Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland
    Tiina Suominen
    Linda L Bachinski
    Satu Auvinen
    Peter Hackman
    Keith A Baggerly
    Corrado Angelini
    Leena Peltonen
    Ralf Krahe
    Bjarne Udd
    European Journal of Human Genetics, 2011, 19 : 776 - 782
  • [7] Gastrointestinal (GI) symptoms in myotonic dystrophy type 1 and type 2 (DM1 and DM2)
    Hilbert, James E.
    Martens, William B.
    Smirnow, Alexis M.
    Moxley, Richard T., III
    ANNALS OF NEUROLOGY, 2008, 64 : S7 - S7
  • [8] The frequency of myotonic dystrophy type 2 (DM2) and type 1 (DM1) mutations in the population
    Suominen, T.
    Bachinski, L. L.
    Auvinen, S.
    Hackman, P.
    Angelini, C.
    Peltonen, L.
    Krahe, R.
    Udd, B.
    NEUROMUSCULAR DISORDERS, 2010, 20 (9-10) : 628 - 628
  • [9] Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland
    Suominen, Tiina
    Bachinski, Linda L.
    Auvinen, Satu
    Hackman, Peter
    Baggerly, Keith A.
    Angelini, Corrado
    Peltonen, Leena
    Krahe, Ralf
    Udd, Bjarne
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2011, 19 (07) : 776 - 782
  • [10] Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2
    Vihola, A
    Bassez, G
    Meola, G
    Zhang, S
    Haapasalo, H
    Paetau, A
    Mancinelli, E
    Rouche, A
    Hogrel, JY
    Laforêt, P
    Maisonobe, T
    Pellissier, JF
    Krahe, R
    Eymard, B
    Udd, B
    NEUROLOGY, 2003, 60 (11) : 1854 - 1857